• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VIGILANT X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G247
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Unspecified Infection (1930); No Code Available (3191)
Event Date 12/21/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.(b)(4).
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to infection.The patient was treated with intravenous antibiotics.There were no additional adverse patient effects reported.The crt-d was explanted.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) had infection.Reportedly, the patient had mechanical valve on blood thinners with high international normalized ratio (inr) which resulted to hematoma in the pocket.The hematoma evacuation for several times had caused infection.The patient was treated with intravenous antibiotics.The device was explanted.There were no additional adverse patient effects reported.
 
Manufacturer Narrative
This supplemental report was created to capture the correction on b5: describe event or problem.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.Patient code 3191 captures the reportable event of surgery and the additional intervention performed by the use of intravenous antibiotics.The returned device was inspected and analyzed upon receipt at our post market quality assurance laboratory.The analysis showed that the device passed all baseline testing and found to anomaly.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) had infection.Reportedly, the patient had mechanical valve on blood thinners with high international normalized ratio (inr) which resulted to hematoma in the pocket.The hematoma evacuation for several times had caused infection.The patient was treated with intravenous antibiotics.The device was explanted.There were no additional adverse patient effects reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIGILANT X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11228113
MDR Text Key241236380
Report Number2124215-2021-01823
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589287
UDI-Public00802526589287
Combination Product (y/n)N
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/22/2022
Device Model NumberG247
Device Catalogue NumberG247
Device Lot Number247988
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/11/2021
Initial Date Manufacturer Received 12/22/2020
Initial Date FDA Received01/25/2021
Supplement Dates Manufacturer Received12/22/2020
03/03/2021
Supplement Dates FDA Received01/26/2021
05/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-